1. Stroomberg HV, Larsen SB, Kjær Nielsen T, et al. Outcomes of biopsy grade group 1 prostate cancer diagnosis in the Danish population. Eur Urol Oncol. In press. DOI: 10.1016/j.euo.2023.10.005.
2. Low-grade prostate cancer: time to stop calling it cancer;Eggener;J Clin Oncol,2022
3. Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients;Samaratunga;Pathology,2024
4. Histopathology of prostate cancer and its precursors;Montironi;Appl Immunohistochem Mol Morphol,2023
5. Cimadamore A, Lopez-Beltran A, Cheng L, Montironi R. Re: George J. Netto, Mahul B. Amin, Eva M. Compérat, et al. Prostate adenocarcinoma grade group 1: rationale for retaining a cancer label in the 2022 World Health Organization classification. Eur Urol. In press. 2023;83:e84–6. DOI: 10.1016/j.eururo.2022.09.015. Eur Urol.